China Regenerative Medicine International Limited (HKG:8158)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Apr 30, 2017	Apr 30, 2015	Apr 30, 2014	Apr 30, 2013	Apr 30, 2012	Apr 30, 2011	Apr 30, 2010	Apr 30, 2009	Apr 30, 2008	Apr 30, 2007	Apr 30, 2006	Apr 30, 2005	Apr 30, 2004
Aesthetic Medical and Beauty Services	85.35M
Aesthetic Medical and Beauty Services Growth	39.52%
Medical Services	5.26M
Medical Services Growth	-36.65%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Apr 30, 2017	Apr 30, 2015	Apr 30, 2014	Apr 30, 2013	Apr 30, 2012	Apr 30, 2011	Apr 30, 2010	Apr 30, 2009	Apr 30, 2008	Apr 30, 2007	Apr 30, 2006	Apr 30, 2005	Apr 30, 2004
Hong Kong	89.93M
Hong Kong Growth	31.62%
China	688.00K
China Growth	-40.69%